semaglutide and metformin for weight loss Frontiers Metformin + Semaglutide for Weight

reinstated December 2025 (status: monitor closely) States that restrict coverage: Michigan restricted to BMI 40 (morbid obesity) with strict prior authorization criteria

In a review of medical charts of people with UC treated at Mayo Clinic, researchers found that two of the four people in the study taking semaglutide for weight loss had a UC flare-up

The short answer: no fasting required

Sore throat is not listed as a common direct side effect of Saxenda, though upper respiratory tract infections and nasopharyngitis are recognised adverse reactions

Other FDA-approved weight management medications provide alternatives worth considering

sourcing data not from a controlled study.) For guidance on identifying legitimate suppliers and verifying purity, see our recommended sources page